Hegazy and colleagues showed that microbiota-reactive CD4+ T cells are normal constituents of the human gut, even though such cells are more abundant in IBD tissue and produce predominantly IL-17A as compared with responses of T cells from blood or intestinal samples of normal controls (171). This evidence concerns the gene CD4 and inflammatory bowel disease.